Lovenox
Product Images NDC 54868-5112

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lovenox (NDC 54868-5112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Lovenox 01)

An instructional illustration showing two gloved hands holding a syringe. Arrows indicate pulling the syringe parts apart, likely demonstrating how to prepare or unlock the syringe before use.*

FDA Label Image

Figure B (Lovenox 02)

An instructional illustration showing a hand holding a syringe injecting medication into the fatty tissue of the lower abdomen near the hip area, with an arrow indicating the direction of injection. This likely demonstrates the proper technique for a subcutaneous injection.*

FDA Label Image

Figure C (Lovenox 03)

An instructional illustration showing a hand holding a syringe with a protective cap partially removed, indicated by a blue arrow pointing away from the syringe. The image likely demonstrates how to prepare the syringe for use, associated with Lovenox by Physicians Total Care, Inc.*

FDA Label Image

Figure D (Lovenox 04)

An illustration showing a gloved hand holding a syringe filled with a clear solution. The image appears to demonstrate the preparation or administration of an injectable medication, with a focus on safe handling techniques.*

FDA Label Image

Figure E (Lovenox 05)

An instructional illustration showing a hand holding a device and pressing it down onto a surface labeled 'Lovenox Re-Sheather' with an arrow indicating the downward motion. The image demonstrates correct placement or usage technique related to the Lovenox Re-Sheather device.*

FDA Label Image

Chemical Structure (Lovenox 06)

Chemical structure of the active ingredient in Lovenox, showing repeating disaccharide units with sodium carboxylate and sulfate groups. Substituents R1 and R2 are defined as hydrogen or sodium sulfate and sulfate or acetyl groups, respectively.*

FDA Label Image

Chemical Structure (Lovenox 07)

Chemical structure diagram showing a molecular formula with sodium (Na), hydroxyl (OH), and sulfonate (NHSO3Na) groups, likely representing the active ingredient of Lovenox.*

FDA Label Image

Figure 1 (Lovenox 08)

A forest plot comparing the relative risk of different patient subgroups treated with UFH (unfractionated heparin) versus Enox (enoxaparin). The plot shows relative risk values and reductions in risk percentages for subgroups defined by sex, age, infarct location, diabetes status, prior MI, fibrinolytic agent, time to treatment, and PCI within 30 days, with an overall summary at the bottom indicating enoxaparin generally shows better outcomes than UFH.*

FDA Label Image

Figure 2 (Lovenox 09)

A Kaplan-Meier hazard distribution plot comparing time to death or myocardial re-infarction for Enoxaparin and UFH over 30 days. The graph shows hazard functions for two groups, with Enoxaparin consistently lower than UFH. An inset graph displays the corresponding hazard functions at 1 year. A table below shows numbers at risk for both groups at multiple time points.*

FDA Label Image

Image Of 100mg/1 mL Label (Package Label 01)

Label for Lovenox 100 mg/1 mL (1.0 mL PFS) distributed by Physicians Total Care, Inc. The label shows the NDC number 54868-5835-0, lot number 0000, and expiration date 01/60, with a barcode and manufacturer noted as Sontet-Genvis US LLC.*

FDA Label Image

Image Of 120mg/0.8 mL Label (Package Label 02)

Lovenox 120MG/0.8ML (0.8ML PFS) label distributed by Physicians Total Care, Inc., Tulsa, OK. The label shows lot number 0000 and expiration date 01/60, with a barcode and the distributor Sanofi-Aventis U.S. LLC, Bridgewater, NJ.*

FDA Label Image

Image Of 40mg/0.4 mL Label (Package Label 03)

Packaging label for Lovenox 40mg/0.4mL prefilled syringe by Physicians Total Care, Inc. The label shows dosage strength as 40mg in 0.4mL volume and includes an expiration date of January 2060. A barcode and distributor information with location in Tulsa, OK, are also visible.*

FDA Label Image

Image Of 60mg/0.6 mL Label (Package Label 04)

Packaging label for Lovenox 60MG/0.6ML (0.6ML PFS) by Physicians Total Care, Inc. The label includes batch lot number and expiration date information along with a barcode.*

FDA Label Image

Image Of 80mg/0.8 mL Label (Package Label 05)

Lovenox 80 mg/0.8 mL label distributed by Physicians Total Care, Inc. The label displays the lot number 0000 and an expiration date of 01/60. It includes a barcode and mentions the manufacturer Sanofi-Aventis U.S. LLC in Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.